Hidefumi Inaba

1.2k total citations
64 papers, 859 citations indexed

About

Hidefumi Inaba is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Hidefumi Inaba has authored 64 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 20 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Oncology. Recurrent topics in Hidefumi Inaba's work include Neuroendocrine Tumor Research Advances (15 papers), Diabetes and associated disorders (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Hidefumi Inaba is often cited by papers focused on Neuroendocrine Tumor Research Advances (15 papers), Diabetes and associated disorders (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Hidefumi Inaba collaborates with scholars based in Japan, United States and Sri Lanka. Hidefumi Inaba's co-authors include Takashi Akamizu, Hiroyuki Ariyasu, Hiroshi Iwakura, Ken Takeshima, Yasushi Furukawa, Shuhei Morita, Leslie J. De Groot, Masahiro Nishi, Shinsuke Uraki and Hiroto Furuta and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Hidefumi Inaba

59 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidefumi Inaba Japan 17 316 285 282 167 135 64 859
Bryan Lin United States 14 298 0.9× 162 0.6× 123 0.4× 72 0.4× 76 0.6× 25 1000
Frank Schuppert Germany 15 230 0.7× 361 1.3× 130 0.5× 133 0.8× 42 0.3× 56 1.1k
Ken Takeshima Japan 14 168 0.5× 145 0.5× 189 0.7× 67 0.4× 66 0.5× 34 476
Claudia Parisi Italy 18 342 1.1× 95 0.3× 395 1.4× 145 0.9× 55 0.4× 47 1.2k
Francesco Paolo Pilato Italy 17 308 1.0× 74 0.3× 534 1.9× 127 0.8× 255 1.9× 41 997
Yalan Bi China 16 221 0.7× 88 0.3× 89 0.3× 48 0.3× 50 0.4× 51 718
Robert Rzepko Poland 16 200 0.6× 55 0.2× 165 0.6× 71 0.4× 69 0.5× 44 711
Louise Rochon Canada 20 272 0.9× 306 1.1× 103 0.4× 32 0.2× 40 0.3× 54 999
Ekmel Tezel Türkiye 17 339 1.1× 103 0.4× 145 0.5× 37 0.2× 48 0.4× 37 942
Cáp J Czechia 16 146 0.5× 563 2.0× 154 0.5× 48 0.3× 41 0.3× 91 835

Countries citing papers authored by Hidefumi Inaba

Since Specialization
Citations

This map shows the geographic impact of Hidefumi Inaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidefumi Inaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidefumi Inaba more than expected).

Fields of papers citing papers by Hidefumi Inaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidefumi Inaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidefumi Inaba. The network helps show where Hidefumi Inaba may publish in the future.

Co-authorship network of co-authors of Hidefumi Inaba

This figure shows the co-authorship network connecting the top 25 collaborators of Hidefumi Inaba. A scholar is included among the top collaborators of Hidefumi Inaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidefumi Inaba. Hidefumi Inaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ueda, Yôko, Hiroshi Iwakura, Asako Doi, et al.. (2025). Tryptophan‐sensing receptor GPR142 expression levels are directly regulated by proinflammatory cytokines in ghrelin‐producing cells. FEBS Open Bio. 15(5). 763–772.
2.
Inaba, Hidefumi, Gen Inoue, Takakazu Sugita, et al.. (2022). Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors. Endocrinology and Metabolism. 37(1). 84–95. 23 indexed citations
3.
Inaba, Hidefumi, et al.. (2022). Serum ketone body measurement in patients with diabetic ketoacidosis. Diabetology International. 13(4). 624–630. 5 indexed citations
4.
Morita, Shuhei, Shinsuke Uraki, Ken Takeshima, et al.. (2022). Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report. BMC Endocrine Disorders. 22(1). 185–185. 27 indexed citations
5.
Inaba, Hidefumi, et al.. (2021). Beneficial effects of sodium glucose cotransporter 2 inhibitors on left ventricular mass in patients with diabetes mellitus. Journal of Diabetes. 13(11). 847–856. 4 indexed citations
6.
Inaba, Hidefumi & Toru Aizawa. (2021). Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives. Frontiers in Endocrinology. 12. 708333–708333. 35 indexed citations
7.
Uraki, Shinsuke, Hiroyuki Ariyasu, Asako Doi, et al.. (2020). MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes. International Journal of Molecular Sciences. 21(8). 2831–2831. 28 indexed citations
8.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2020). Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report. BMC Endocrine Disorders. 20(1). 6 indexed citations
9.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2020). Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors. Cancer Science. 111(5). 1468–1477. 109 indexed citations
10.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2019). Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study. Clinical Endocrinology. 91(6). 786–792. 23 indexed citations
11.
Inaba, Hidefumi, Hiroyuki Ariyasu, Shohei Matsuno, et al.. (2018). Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 Antibody. Internal Medicine. 57(14). 2029–2034. 36 indexed citations
12.
Ueda, Yôko, Hiroshi Iwakura, Mika Bando, et al.. (2018). Differential role of GPR142 in tryptophan-mediated enhancement of insulin secretion in obese and lean mice. PLoS ONE. 13(6). e0198762–e0198762. 16 indexed citations
13.
Ariyasu, Hiroyuki, Hidefumi Inaba, Takayuki Ota, et al.. (2018). Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma. In Vivo. 32(2). 345–351. 25 indexed citations
14.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2016). Diabetic ketoacidosis in a patient with acromegaly and central diabetes insipidus treated with octreotide long-acting release. Diabetology International. 8(2). 237–242. 3 indexed citations
15.
Inaba, Hidefumi, Leslie J. De Groot, & Takashi Akamizu. (2016). Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease. Frontiers in Endocrinology. 7. 120–120. 27 indexed citations
16.
Inaba, Hidefumi, Satoru Suzuki, Satoshi Shigematsu, et al.. (2009). Lymphocytic Infundibuloneurohypophysitis: Long-Term Follow-Up of a Case Cured with Glucocorticoid. Medical Principles and Practice. 19(1). 79–81. 9 indexed citations
17.
Suzuki, Sawako, et al.. (2009). Atypical early onset of diabetes, deafness and lung cancer in a male patient with mitochondrial mutations in peripheral mononuclear cells. BMJ Case Reports. 2009. bcr0320091648–bcr0320091648. 2 indexed citations
18.
Inaba, Hidefumi, et al.. (2009). Leydig Cell Tumor and Malignant Lymphoma in a Patient with Nonclassical 21-Hydroxylase Deficiency. Internal Medicine. 48(8). 601–605. 7 indexed citations
19.
Suzuki, Satoru, Jun-ichirou Mori, Masayuki Kobayashi, et al.. (2003). Cell-specific expression of NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine-binding protein (p38CTBP). European Journal of Endocrinology. 148(2). 259–268. 16 indexed citations
20.
Ito, Yoshiaki, et al.. (1998). [A case of primary lung cancer presenting as pneumothorax].. PubMed. 51(2). 150–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan Lin Breakdown of academic impact, for papers by Frank Schuppert Breakdown of academic impact, for papers by Ken Takeshima Breakdown of academic impact, for papers by Claudia Parisi Breakdown of academic impact, for papers by Francesco Paolo Pilato Breakdown of academic impact, for papers by Yalan Bi Breakdown of academic impact, for papers by Robert Rzepko Breakdown of academic impact, for papers by Louise Rochon Breakdown of academic impact, for papers by Ekmel Tezel Breakdown of academic impact, for papers by Cáp J
Rankless by CCL
2026